1. Home
  2. Live Updates
  3. Ounjaro

Live Breaking News & Updates on Ounjaro

Stay informed with the latest breaking news from Ounjaro on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Ounjaro and stay connected to the pulse of your community

Zepbound, Mounjaro shortages drag on

Limited supply of Zepbound and Mounjaro solutions continues, with shortages expected to last until 2024. Eli Lilly plans to apply for another indication.

Eli-lilly , Zepbound , Ounjaro , Imited-supply , Hortages , Da , Irzepatide-injection , Eight-loss-drug , Ype-2-diabetes-medication , He-fda , Imited ,

4 Weight-Loss Drug Stocks With 100% Upside Potential in Next 12 Months

"If you look at AI, there are tons of ETFs out there," Tema CEO Maurits Pot says. "In weight-loss drugs there's one. We're the only one."

Denmark , United-states , America , Danish , Charles-barkley , Elon-musk , Zealand-pharma , Whoopi-goldberg , Ozempic-wegovy , Geoff-meacham , World-health-organization , Novo-nordisk

American pharma major Eli Lilly's big focus on India: Will the company's strategy work?

American pharma major Eli Lilly sees India as its launchpad for a new growth trajectory, using its new drugs for diabetes and obesity as the fuel. Will this strategic pivot work? - Issue Date: Mar 31, 2024

Germany , India , United-states , United-kingdom , Vietnam , Republic-of , Denmark , American , Danish , Sheetal-sapale , Lilly-indian , Sun-pharma

Mounjaro shortage update: Is it on backorder and when will it be back in stock?

Mounjaro and Zepbound manufacturer Eli Lilly has battled supply issues since weight loss injectables took off. Those who rely on Mounjaro are currently facing shortages and backorders and may be for the foreseeable future.

United-states , North-carolina , Eli-lilly , Ely-lilly , David-ricks , Hollywood-ozempic , Cnn , Novo-nordisk , Drug-administration , Eight-loss , Iabetes-management , Ounjaro

Health systems double down on weight loss programs

By 2030, 51% of the world's population is expected to have obesity, driving the demand for GLP-1 drugs. Learn how health systems are responding.

United-states , American , Americans , Laura-davisson , Andres-acosta , World-obesity-federation , American-medical-association , World-obesity , Mayo-clinic , Obesity , Lucagon-like-peptide-1-receptor-agonists , Zempic

Weight loss wonder drugs: Everything you need to know

A simple shot used for years to treat diabetes is changing modern medicine as we know it.

Stella-hernandez , Cyreia-sandlin , Debra-becwar , Vidya-kidambi , Drug-administration , Froedtert-hospital , Doctor , R-vidya-kidambi , Ospital , Eight , Iabetes , Ealth

US pharma giant Eli Lilly plans to introduce its blockbuster anti-diabetes drug Mounjaro to India next year, to target weight loss market

This announcement was made by CEO David Ricks in an exclusive interview with Business Today on Wednesday.



India , United-kingdom , United-states , American , David-ricks , Eli-lilly , Orexigen-therapeutics , Roche-pharmaceuticals , National-family-health , Novo-nordisk , International-diabetes-federation , Vivus-pharmaceuticals

Zealand Pharma shares surge on liver disease drug trial data, Health News, ET HealthWorld

Pharma: Seeking to challenge obesity treatment market leaders Novo Nordisk and Eli Lilly, Zealand and unlisted Boehringer in June 2023 reported promising phase 2 weight-loss trial results, with the largest and most expensive final stage of testing still to be cleared.

Germany , Zealand-pharma , Eli-lilly , Lilly-mounjaro , Boehringer-ingelheim , Novo-nordisk , Pharma , Epbound , Egovy , Ovo-nordisk , Ounjaro , Ealth-news

NATIONALLY RANKED ROSEN LAW FIRM Encourages Altimmune, Inc.

NEW YORK, Feb. 19, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities...

China , New-york , United-states , Chinese , Phillip-kim , Laurence-rosen , Nasdaq , Linkedin , Altimmune-inc , Securities-class-action-services , Facebook , Twitter

Can Ozempic treat your depression? Early signs point to yes

Add depression to the growing list of chronic diseases that obesity medicines might alleviate. Signs of improved mental health are showing up in the health records of people who take

Toronto , Ontario , Canada , Novo-nordisk-wegovy , Rodrigo-mansur , Matthew-hayes , Lisa-jarvis , Eli-lilly-co , University-of-toronto , Centers-for-disease , Epic-research , Drug-administration